novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Associações fixas no tratamento da HTA

21 Janeiro 2014

Jorge Polónia
Cardiologista
Hospital Pedro Hispano, Matosinhos

As artérias como modeladoras do risco cardio e cerebrovascular

21 Janeiro 2014
0

Inibição do SRAA e bloqueio dos canais do cálcio- Parte 2

21 Janeiro 2014
0

-->